New biological insights on the link between radiation exposure and breast cancer risk

Journal of Mammary Gland Biology and Neoplasia

Volumn 18, Issue 1, 2013, Pages 3-13

  Barcellos Hoff, Mary Helen ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Carcinogenesis; DNA damage; Ionizing radiation; Microenvironment; Ovarian hormones; Transformation

Indexed keywords

AGE; BREAST CANCER; CANCER PATIENT; CANCER RISK; CANCER SURVIVOR; CANCER SUSCEPTIBILITY; DNA DAMAGE; GENOMIC INSTABILITY; MENOPAUSE; NONHUMAN; PUBERTY; RADIATION CARCINOGENESIS; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RADIATION HAZARD; REVIEW; STEM CELL;

AGE FACTORS; ANIMALS; BREAST NEOPLASMS; CELLULAR MICROENVIRONMENT; FEMALE; GENOMIC INSTABILITY; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY GLANDS, HUMAN; RADIATION TOLERANCE; RISK; STEM CELLS; WOMEN'S HEALTH;

EID: 84874427889     PISSN: 10833021     EISSN: 15737039     Source Type: Journal    
DOI: 10.1007/s10911-013-9272-x     Document Type: Review

References (114)

1. Ronckers CM, Erdmann CA, Land CE. Radiation and breast cancer: a review of current evidence. Breast Cancer Res. 2005;7:21-32.
2. Fry RJM, Powers-Risius P, Alpen EL, et al. High-LET radiation carcinogenesis. Adv Space Res. 1983;3:241-8.
3. Mettler FA. Medical effects and risks of exposure to ionising radiation. J Radiol Prot. 2012;32(1):N9-N13.
4. UNSCEAR. Sources and effects of ionizing radiation. New York: United Nations; 2006.
5. Mettler FA, Bhargavan M, Faulkner K, et al. Radiologic and Nuclear Medicine Studies in the United States and Worldwide: frequency, radiation dose, and comparison with other radiation sources - 1950-20071. Radiology. 2009;253(2):520-31.
6. Tokunaga M, Land CE, Aoki Y, et al. Proliferative and nonproliferative breast disease in atomic bomb survivors. Results of a histopathologic review of autopsy breast tissue. Cancer. 1993;72(5):1657-65.
7. Boice Jr JD, Preston D, Davis FG, et al. Frequent chest x-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. Radiat Res. 1991;125:214-22.
8. Hancock SL, Tucker MA, Hoppe RT. Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst. 1993;85(1):25-31.
9. Howe GR, McLaughlin J. Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivor study. Radiat Res. 1996;145:694-707.
10. Boice Jr JD. Radiation and breast carcinogenesis. Med Pediatr Oncol. 2001;36:508-13.
11. Preston DL, Mattsson A, Holmberg E, et al. Radiation effects on breast cancer risk: a pooled analysis of eight cohorts. Radiat Res. 2002;158(2):220-35.
12. Hoffman DA, Lonstein JE, Morin MM, et al. Breast cancer in women with scoliosis exposed to multiple diagnostic rays. J Natl Cancer Inst. 1989;81(17):1307-12.
13. Ostroumova E, Preston DL, Ron E, et al. Breast cancer incidence following low-dose rate environmental exposure: Techa River Cohort, 1956-2004. Br J Cancer. 2008;99(11):1940-5.
14. Shore RE, Hildreth N, Dvoretsky P, et al. Thyroid cancer among persons given X-ray treatment in infancy for an enlarged thymus gland. Am J Epidemiol. 1993;137(10):1068-80.
15. Hajo Z, Gaël PH, Maria B. Epidemiological investigations of aircrew: an occupational group with low-level cosmic radiation exposure. J Radiol Prot. 2012;32(1):N15.
16. Preston DL, Ron E, Tokuoka S, et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res. 2007;168(1):1-64.
17. Pawel D, Preston D, Pierce D, et al. Improved estimates of cancer site-specific risks for a-bomb survivors. Radiat Res. 2008;169:87-98.
18. Preston DL, Pierce DA, Shimizu Y, et al. Dose response and temporal patterns of radiation-associated solid cancer risks. Health Phys. 2003;85(1):43-6.
19. Pierce DA, Shimizu Y, Preston DL, et al. Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990. Radiat Res. 1996;146(1):1-27.
20. Boice Jr JD, Harvey EB, Blettner M, et al. Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med. 1992;326(12):781-5.
21. Morin Doody M, Lonstein JE, Stovall M, et al. Breast cancer mortality after diagnostic radiography: findings from the U.S. Scoliosis Cohort Study. Spine. 2000;25(16):2052-63.
22. Mattsson A, Ruden B-I, Wilking N, et al. Radiation-induced breast cancer: long-term follow-up of radiation therapy for benign breast disease. J Natl Cancer Inst. 1993;85:1679-85.
23. Shore RE, Hildreth N, Woodard E, et al. Breast cancer among women given X-ray therapy for acute postpartum mastitis. J Natl Cancer Inst. 1986;77(3):689-96.
24. Lundell M, Mattsson A, Karlsson P, et al. Breast cancer risk after radiotherapy in infancy: a pooled analysis of two Swedish cohorts of 17,202 infants. Radiat Res. 1999;151(5):626-32.
25. Hill DA, Preston-Martin S, Ross RK, et al. Medical radiation, family history of cancer, and benign breast disease in relation to breast cancer risk in young women, USA. Cancer Causes Control. 2002;13(8):711-8.
26. Durante M, Cucinotta FA. Heavy ion carcinogenesis and human space exploration. Nat Rev Cancer. 2008;8(6):465-72.
27. Imaoka T, Nishimura M, Daino K, et al. Influence of Age on the Relative Biological Effectiveness of Carbon Ion Radiation for Induction of Rat Mammary Carcinoma. Int J Radiat Oncol Biol Phys 2012.
28. Stovall M, Smith SA, Langholz BM, et al. Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys. 2008;72(4):1021-30.
29. Cohn BA, Wolff MS, Cirillo MP, et al. DDT and breast cancer in young women: new data on the significance of age at exposure. Environ Health Perspect. 2007;115(10):1406-14.
30. Henderson TO, Amsterdam A, Bhatia S, et al. Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Ann Intern Med. 2010;152(7):444-55.
31. Van Leeuwen FE, Klokman WJ, Stovall M, et al. Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst. 2003;95(13):971-80.
32. Castiglioni F, Terenziani M, Carcangiu ML, et al. Radiation effects on development of HER2-positive breast carcinomas. Clin Cancer Res. 2007;13(1):46-51.
33. Broeks A, Braaf LM, Wessels LF, et al. Radiation-associated breast tumors display a distinct gene expression profile. Int J Radiat Oncol Phys. 2010;76(2):540-7.
34. Inskip PD, Robison LL, Stovall M, et al. Radiation dose and breast cancer risk in the childhood cancer survivor study. J Clin Oncol. 2009;27(24):3901-7.
35. Mertens AC, Liu Q, Neglia JP, et al. Cause-specific late mortality among 5-year survivors of childhood cancer: the childhood cancer survivor study. J Natl Cancer Inst. 2008;100(19):1368-79.
36. Schedin P. Pregnancy-associated breast cancer and metastasis. Nat Cancer Rev. 2006;6(4):281-91.
37. Lyons TR, O'Brien J, Borges VF, et al. Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2. Nat Med. 2011;17(9):1109-15.
38. Clifton KH, Sridharan BN, Douple EB. Mammary carcinogenesis-enhancing effect of adrenalectomy in irradiated rats with pituitary tumor MtT-F4. J Natl Cancer Inst. 1975;55(2):485-7.
39. Sivaraman L, Conneely OM, Medina D, et al. p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis. Proc Natl Acad Sci U S A. 2001;98(22):12379-84.
40. Clifton KH, Tanner MA, Gould MN. Assessment of radiogenic cancer initiation frequency per clonogenic rat mammary cell in vivo. Cancer Res. 1986;46:2390-5.
41. Potten CS, Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development. 1990;110(4):1001-20.
42. Welm BE, Tepera SB, Venezia T, et al. Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev Biol. 2002;245(1):42-56.
43. Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105-11.
44. Visvader JE, Lindeman GJ. Mammary stem cells and mammopoiesis. Cancer Res. 2006;66(20):9798-801.
45. Smith G, Medina D. Re-evaluation of mammary stem cell biology based on in vivo transplantation. Breast Cancer Res. 2008;10(1):203.
46. Smith GH, Chepko G. Mammary epithelial stem cells. Microsc Res Tech. 2001;52(2):190-203.
47. Kordon EC, Smith GH. An entire functional mammary gland may comprise the progeny from a single cell. Development. 1998;125(10):1921-30.
48. Russo J, Tait L, Russo IH. Susceptibility of the mammary gland to carcinogenesis. III. The cell of origin of rat mammary carcinoma. Am J Pathol. 1983;113(1):50-66.
49. Russo J, Russo IH. Experimentally induced mammary tumors in rats. Breast Cancer Res Treat. 1996;39(1):7-20.
50. Russo J, Tay LK, Russo IH. Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat. 1982;2(1):5-73.
51. Russo J, Russo IH. Biological and molecular bases of mammary carcinogenesis. Lab Invest. 1987;57(2):112-37.
52. Thordarson G, Jin E, Guzman RC, et al. Refractoriness to mammary tumorigenesis in parous rats: is it caused by persistent changes in the hormonal environment or permanent biochemical alterations in the mammary epithelia? Carcinogenesis. 1995;16:2847-53.
53. Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 Is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2007;1(5):555-67.
54. Cairns J. Somatic stem cells and the kinetics of mutagenesis and carcinogenesis. Proc Natl Acad Sci U S A. 2002;99(16):10567-70.
55. Booth D, Haley JD, Bruskin AM, et al. Transforming growth factor-B3 protects murine small intestinal crypt stem cells and animal survival after irradiation, possibly by reducing stem-cell cycling. Int J Cancer. 2000;86(1):53-9.
56. Shackleton M, Vaillant F, Simpson KJ, et al. Generation of a functional mammary gland from a single stem cell. Nature. 2006;439(7072):84-8.
57. Woodward WA, Chen MS, Behbod F, et al. WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. PNAS. 2007;104(2):618-23.
58. Kamiya K, Gould MN, Clifton KH. Differential control of alveolar and ductal development in grafts of monodispersed rat mammary epithelium. 1990.
59. Kamiya K, Gould MN, Clifton KH. Quantitative studies of ductal versus alveolar differentiation from rat mammary clonogens. Proc Soc Exp Biol Med. 1998;219(3):217-25.
60. Kamiya K, Kim ND, Gould MN, et al. Repair of potentially lethal damage in rat mammary clonogens following irradiation in organoid culture. Int J Radiat Biol. 1991;59(5):1207-16.
61. Shimada Y, Yasukawa-Barnes J, Kim RY, et al. Age and radiation sensitivity of rat mammary clonogenic cells. Radiat Res. 1994;137:118-23.
62. Ariazi JL, Haag JD, Lindstrom MJ, et al. Mammary glands of sexually immature rats are more susceptible than those of mature rats to the carcinogenic, lethal, and mutagenic effects of N-nitroso- N-methylurea. Mol Carcinog. 2005;43(3):155-64.
63. Kamiya K, Yasukawa-Barnes J, Mitchen JM, et al. Evidence that carcinogenesis involves an imbalance between epigenetic high-frequency initiation and suppression of promotion. Proc Natl Acad Sci USA. 1995;92:1332-6.
64. Kennedy AR, Little JB. Protease inhibitors suppress radiation-induced malignant transformation in vitro. Nature. 1978;276(5690):825-6.
65. Kennedy AR, Fox M, Murphy G, et al. Relationship between x-ray exposure and malignant transformation in C3H 10T1/2 cells. Proc Natl Acad Sci U S A. 1980;77(12):7262-6.
66. Britt K, Ashworth A, Smalley M. Pregnancy and the risk of breast cancer. Endocr Relat Cancer. 2007;14(4):907-33.
67. Siwko SK, Dong J, Lewis MT, et al. Evidence that an early pregnancy causes a persistent decrease in the number of functional mammary epithelial stem cells - implications for pregnancy-induced protection against breast cancer. Stem Cells. 2008;26(12):3205-9.
68. Britt K, Kendrick H, Regan J, et al. Pregnancy in the mature adult mouse does not alter the proportion of mammary epithelial stem/progenitor cells. Breast Cancer Res. 2009;11(2):R20.
69. Liu B, McDermott S, Khwaja S, et al. The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells. Proc Natl Acad Sci USA. 2004;101:4158-63.
70. Chen MS, Woodward WA, Behbod F, et al. Wnt/beta-catenin mediates radiation resistance of Sca1+ progenitors in an immortalized mammary gland cell line. J Cell Sci. 2007;120(3):468-77. doi: 10.1242/jcs.03348.
71. Nguyen NH, Oketch HA, Geyer FC, et al. Radiation acts on the microenvironment to affect breast carcinogenesis by distinct mechanisms that decrease breast cancer latency and affect tumor type. Cancer Cell. 2011;19:640-51.
72. Medina D, Oborn CJ, Kittrell FS, et al. Properties of mouse mammary epithelial cell lines characterized by in vivo transplantation and in vitro immunocytochemical methods. J Natl Cancer Inst. 1986;76(6):1143-56.
73. Terzaghi M, Little JB. X-radiation-induced transformation in C3H mouse embryo-derived cell line. Cancer Res. 1976;36:1367-74.
74. DeOme KB, Miyamoto MJ, Osborn RC, et al. Detection of inapparent nodule transformed cells in the mammary gland tissues of virgin female BALB/cfC3H mice. Cancer Res. 1978;38:2103-11.
75. Ethier SP, Ullrich RL. Detection of ductal dysplasia in mammary outgrowths derived from carcinogen-treated virgin female BALB/c mice. Cancer Res. 1982;42:1753-60.
76. Terzaghi-Howe M. Inhibition of carcinogen-altered rat tracheal epithelial cell proliferation by normal epithelial cells in vivo. Carcinogenesis. 1986;8:145-50.
77. Farber I. Possible etiologic mechanisms in chemical carcinogenesis. Environ Health Perspect. 1987;75:65-70.
78. Banerjee MR, Chakraborty S, Kinder D, et al. Cell biology of mouse mammary carcinogenesis in organ culture. In: Medina D, Kidwell W, Heppner G, et al., editors. Cellular and molecular biology of mammary cancer. New York: Plenum Press; 1987. p. 353-80.
79. Ethier SP, Adams LM, Ullrich RL. Morphological and histological characteristics of mammary dysplasias occurring in cell dissociation-derived murine mammary outgrowths. Cancer Res. 1984;44:4517-22.
80. Ethier SP, Ullrich RL. Induction of mammary tumors in virgin female BALB/c mice by single low doses of 7,12-dimethylbenz[a]anthracene. J Natl Cancer Inst. 1982;69(5):1199-203.
81. Ethier SP, Ullrich RL. Factors influencing expression of mammary ductal dysplasia in cell dissociation-derived murine mammary outgrowths. Cancer Res. 1984;44:4523-7.
82. Adams LM, Ethier SP, Ullrich RL. Enhanced in vitro proliferation and in vivo tumorigenic potential of mammary epithelium from BALB/c mice exposed in vivo to gamma-radiation and/or 7,12-dimethylbenz[a]anthracene. Cancer Res. 1987;47(16):4425-31.
83. Ullrich RL. The rate of progression of radiation-transformed mammary epithelial cells is enhanced after low-dose-rate neutron irradiation. Radiat Res. 1986;105:68-75.
84. Kamiya K, Higgins PD, Tanner MA, et al. Kinetics of mammary clonogenic cells and rat mammary cancer induction by X-rays or fission neutrons. J Radiat Res (Tokyo). 1999;40(Suppl):128-37.
85. Bissell MJ, Barcellos-Hoff MH. The influence of extracellular matrix on gene expression: is structure the message? J Cell Sci. 1987;8:327-43.
86. Decosse JJ, Gossens CL, Kuzma JF, et al. Breast cancer: induction of differentiation by embryonic tissue. Science. 1973;181:1057-8.
87. Cooper M, Pinkus H. Intrauterine transplantation of rat basal cell carcinoma as a model for reconversion of malignant to benign growth. Cancer Res. 1977;37:2544-52.
88. Fujii H, Cunha GR, Norman JT. The induction of adenocarinomatous differentiation in neoplastic bladder epithelium by an embryonic prostatic inducer. J Urol. 1982;128:858-61.
89. Finak G, Bertos N, Pepin F, et al. Stromal gene expression predicts clinical outcome in breast cancer. Nat Med. 2008;14:518-27.
90. Farber E. Pre-cancerous steps in carcinogenesis. Their physiological adaptive nature. Biochem Biophys Acta. 1984;738:171-80.
91. Barcellos-Hoff MH. The potential influence of radiation-induced microenvironments in neoplastic progression. J Mammary Gland Biol Neoplasia. 1998;3:165-75.
92. Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer. 2001;1(1):1-11.
93. Tlsty TD. Cell-adhesion-dependent influences on genomic instability and carcinogenesis. Curr Opin Cell Biol. 1998;10(5):647-53.
94. Tubiana M, Aurengo A, Averbeck D, et al. Dose-effect relationships and estimation of the carcinogenic effect of low doses of ionizing radiation. Paris: Académie des Sciences - Académie Nationale de Médecine; 2005. p. 1-94.
95. Barcellos-Hoff MH, Park C, Wright EG. Radiation and the microenvironment - tumorigenesis and therapy. Nat Rev Cancer. 2005;5(11):867-75.
96. Little MP, Filipe JAN, Prise KM, et al. A model for radiation-induced bystander effects, with allowance for spatial position and the effects of cell turnover. J Theor Biol. 2005;232(3):329-38.
97. Nguyen DH, Oketch-Rabah HA, Illa-Bochaca I, et al. Radiation acts on the microenvironment to affect breast carcinogenesis by distinct mechanisms that decrease cancer latency and affect tumor type. Cancer Cell. 2011;19(5):640-51.
98. Barcellos-Hoff MH, Ravani SA. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res. 2000;60:1254-60.
99. Kaplan HS, Carnes WH, Brown MB, et al. Indirect Induction of Lymphomas in Irradiated Mice: I. Tumor Incidence and Morphology in Mice Bearing Nonirradiated Thymic Grafts. Cancer Res. 1956;16(5):422-5.
100. Morgan JE, Gross JG, Pagel CN, et al. Myogenic cell proliferation and generation of a reversible tumorigenic phenotype are triggered by preirradiation of the recipient site. J Cell Biol. 2002;157(4):693-702.
101. Mancuso M, Pasquali E, Leonardi S, et al. Oncogenic bystander radiation effects in Patched heterozygous mouse cerebellum. Proc Natl Acad Sci (USA). 2008;105(34):12445-50.
102. Medina D, Kittrell FS, Shepard A, et al. Biological and genetic properties of the p53 null preneoplastic mammary epithelium. FASEB J. 2002;16(8):881-3.
103. Cicalese A, Bonizzi G, Pasi CE, et al. The Tumor Suppressor p53 Regulates Polarity of Self-Renewing Divisions in Mammary Stem Cells. Cell. 2009;138(6):1083-95.
104. Tao L, Roberts AL, Dunphy KA, et al. Repression of Mammary Stem/Progenitor Cells by P53 is Mediated by Notch and Separable from Apoptotic Activity. STEM CELLS 2010:N/A-N/A.
105. Herschkowitz JI, Zhao W, Zhang M, et al. Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells. Proc Natl Acad Sci 2011.
106. Jensen EV, Jordan VC. The estrogen receptor: a model for molecular medicine. Clin Cancer Res. 2003;9(6):1980-9.
107. Allred DC, Wu Y, Mao S, et al. Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution. Clin Cancer Res. 2008;14(2):370-8.
108. Parise CA, Bauer KR, Brown MM, et al. Breast Cancer Subtypes as Defined by the Estrogen Receptor (ER), Progesterone Receptor (PR), and the Human Epidermal Growth Factor Receptor 2 (HER2) among Women with Invasive Breast Cancer in California, 1998-2004. Breast J. 2009;15(6):593-602.
109. Sell S, Pierce GB. Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab Invest. 1994;70(1):6-22.
110. Lim E, Wu D, Pal B, et al. Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways. Breast Cancer Res. 2010;12(2):R21.
111. Prat A, Parker JS, Karginova O, et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res. 2010;12(5):R68.
112. Bouras T, Pal B, Vaillant F, et al. Notch signaling regulates mammary stem cell function and luminal cell-fate commitment. Cell Stem Cell. 2008;3(4):429-41.
113. Purton LE, Scadden DT. Limiting factors in murine hematopoietic stem cell assays. Cell Stem Cell. 2007;1(3):263-70.
114. Mao JH, Li J, Jiang T, et al. Genomic instability in radiation-induced mouse lymphoma from p53 heterozygous mice. Oncogene. 2005;24(53):7924-34.